Professor of Biostatistics Jon Wakefield is co-author of a recent paper that notes the explosion in geographic studies in low- and middle-income countries and investigates the extent to which accounting for the sample design affects the predictive performance at the aggregate level of interest for health policy decisions.
In the News
Daniela Witten, professor of biostatistics and statistics, is quoted in this piece that examines how statistical thinking and eugenicist thinking are intertwined and delves into the difficulty of breaking the legacy of eugenics and false objectivity.
Peter Gilbert, research professor of biostatistics and a biostatistician at Fred Hutch, comments on assessing safety and efficacy after an Emergency Use Authorization has been approved. Gilbert has helped design clinical trials for the leading U.S. vaccine candidates.
Six Biostatistics alumni are among the 50 Changemakers recognized by the School of Public Health as part of its 50th anniversary celebration. Congratulations to Garnet Anderson, Gary Churchill, Jeffrey Leek, Kung-Yee Liang, Xihong Lin, and Clarice R. Weinberg.
Professor of Biostatistics Tom Fleming is a member of WHO’s Solidarity Vaccines Trial group. He discusses the group's COVID-19 vaccine mega-trial, to start this month with a small study in Latin America.
Thomas R. Fleming, professor and former chair of biostatistics, received the 2020 Ward Cates Spirit Award from the HIV Prevention Trials Network (HPTN). The honor recognizes Fleming’s dedication, passion, and tireless pursuit of ensuring clinical trials are well designed, properly implemented, and correctly interpreted.
Fred Hutchinson Cancer Research Center biostatistician Dr. Ruth Etzioni was just named the inaugural recipient of the Rosalie & Harold Rea Brown Endowed Chair. The new endowed chair will help advance Etzioni’s population science research, which focuses on cancer screening and early detection, particularly in breast and prostate cancers. Etzioni is also a UW affiliate professor of biostatistics.
Elizabeth “Betz” Halloran, professor of biostatistics, is quoted in this piece about pharma companies using different playbooks to test their Covid-19 shots, noting the first team to claim victory may not have the best formula.